| Journal | Advances in clinical chemistry |
| Study Type | Clinical Study |
| Population | Human participants |
This comprehensive review establishes the scientific foundation for the ‘runner’s high’ phenomenon, specifically highlighting the role of endocannabinoids alongside other neuromodulators in exercise-induced euphoria and pain relief. Understanding these mechanisms helps clinicians better counsel patients on exercise as medicine and provides insight into how physical activity influences the same endocannabinoid system targeted by cannabis therapeutics.
This review chapter systematically examines biomarkers across cardiovascular, metabolic, hormonal, inflammatory, and neuromodulatory systems during endurance exercise. The authors detail how exercise activates multiple physiological pathways, including the endocannabinoid system, which contributes to exercise-induced analgesia and mood enhancement. The review covers established markers like heart rate variability and VOโmax alongside emerging indicators such as oxidative stress markers and microRNAs. Notably, the chapter positions endocannabinoids as key players in the runner’s high phenomenon, working alongside ฮฒ-endorphins, dopamine, serotonin, and BDNF to modulate pain perception and mood states.
“This reinforces what I observe clinicallyโthat exercise and cannabis can work synergistically through shared endocannabinoid pathways. Patients who maintain regular exercise often require lower cannabis doses for pain and anxiety management, likely due to this overlapping mechanism.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- How do endocannabinoids produced during exercise relate to cannabis therapy?
- Can exercise biomarkers help predict patient response to cannabis treatment?
- Should cannabis patients modify their exercise routines during treatment?
- How might cannabis affect exercise-related inflammatory biomarkers?
- Can exercise enhance the therapeutic benefits of medical cannabis?
FAQ
How do endocannabinoids produced during exercise relate to cannabis therapy?
Exercise naturally increases endocannabinoid levels, contributing to the “runner’s high” and pain relief through the same CB1 and CB2 receptors targeted by cannabis. This suggests that exercise-induced endocannabinoid elevation may provide insights into optimal dosing and timing for cannabis-based therapies, particularly for pain and mood disorders.
Can exercise biomarkers help predict patient response to cannabis treatment?
Baseline endocannabinoid levels and related neuromodulators like BDNF and ฮฒ-endorphins may serve as predictive biomarkers for cannabis treatment response. Patients with higher exercise-induced endocannabinoid production might require different cannabis dosing strategies compared to sedentary individuals with potentially dysregulated endocannabinoid systems.
Should cannabis patients modify their exercise routines during treatment?
Exercise-induced endocannabinoid release may potentiate cannabis effects, particularly for pain relief and mood regulation. Clinicians should monitor cardiovascular parameters like heart rate variability and blood pressure when patients combine cannabis use with endurance exercise, as both can affect autonomic function.
Cannabis may modulate exercise-induced inflammatory responses through CB2 receptor activation, potentially altering recovery biomarkers and training adaptation. This interaction could be beneficial for managing exercise-related inflammation but may also affect the natural adaptive stress response necessary for fitness improvements.
Can exercise enhance the therapeutic benefits of medical cannabis?
The synergistic activation of endocannabinoid pathways through both exercise and cannabis may amplify therapeutic effects for conditions like chronic pain and anxiety. Exercise-induced increases in BDNF and other neuromodulators may also enhance cannabis-mediated neuroprotection and mood stabilization.